QUANTSHARES US MARKET NEUTRAL MOMENTUM F: (AMEX: MOM)
$23.80
-0.01 (-0.04%)
Volume 400
May 17 02:00 PM ET
| Previous Close | 23.81 |
| Open | 23.78 |
| Bid | 19.70 |
| Ask | 24.36 |
| Day Low-High | 23.78-23.80 |
| 52wk Low-High | 23.70-27.33 |
| Avg Volume | 400 |
| NAV | 24.64 |
| Discount | -0.83 |
| Expense Ratio | 1.49% |
| Dividend (Yield) | $0.00 (0.00%) |
| Issuer | FFCM LLC |
| MOM External Home Page >> | |
BENCHMARK for MOM
DOW JONES US THEMATIC MARKET NEUTRAL MOM
The target index, which is compiled by Dow Jones Indexes, is equal weighted, dollar neutral, sector neutral and is not levered. The index rebalances monthly by identifying the highest momentum stocks as long positions and lowest momentum stocks as short positions, of approximately equal dollar amounts, within each sector.
FUND SUMMARY FOR MOM
QUANTSHARES US MARKET NEUTRAL MOMENTUM F
The Fund seeks performance results that correspond to the price and yield performance, before fees and expenses of the Dow Jones U.S. Thematic Market Neutral Momentum Index.
Zacks ETF Rank : MOM
Zacks ETF Rank: 0 - Not Rated 
| |
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Zacks Commentary For MOM
Zacks Blog: iShares Launches 5 US-Focused ETFs
Apr, 18 2013
Zacks Blog: iShares Files for Momentum-Based ETF
Jan, 28 2013
Zacks Blog: QuantShares Files for Half a Dozen ETFs
Oct, 23 2012
Zacks Blog: Uncertain about the Economy? Try Market Neutral ETFs
Oct, 03 2012
News For MOM
Miraculins Reports First Quarter Financial Results for Fiscal 2013 - Marketwire
Apr 26, 2013
Miraculins Reports First Quarter Financial Results for Fiscal 2013 - Marketwire Canada
Apr 26, 2013
Miraculins Leads Future of Global Health Tech Innovation - Accesswire-Tnw
Apr 18, 2013
Miraculins Executes Term Sheet to Acquire the SCOUT DS(R) Non-Invasive Diabetes Screening Technology - Marketwire Canada
Apr 15, 2013
